Feb. 5 at 2:05 PM
$BCTX This has gone down 90% over the last 12 months, and we are at year lows. It is being heavily shorted and the trend is down -- I got it. How close are they to launching? Can anyone talk to that? They are being fast tracked, and they are exceeding benchmarks and "We look forward to confirming these findings in BriaCell's ongoing pivotal Phase 3 study with overall survival as its primary endpoint." I only have a small position right now. I'm no expert of bio companies, but I have seen a pattern of dilution, especially when they are getting ready to launch - but in this case, with the effectiveness, and wide application to breast cancer patients, I think a buy-out would make sense from one of the big boys.
